Nirsevimab for the Prevention of RSV in Infants
Apr
3
6:00 PM18:00

Nirsevimab for the Prevention of RSV in Infants

Register Here Space is limited. There is no cost for this event.

Join us for a presentation on RSV Bunden in infants, Nirsevimab characteristics, clinical development and implementation of policy. Q&A will follow presentation.

Event Details:

Date: April 3rd, 2024

Check-in: 6pm. Presentation starts promptly at 6:30pm.

Speaker: Morgan Anderson, PharmD, BCIDP, Medical Science Liaison

Location: Beatrix, 155 N. Wacker Drive Suite 100 | Chicago, IL 60606*

Dinner will be provided.

*No Valet is available at this location

Disclaimer: This program is non-promotional and sponsored by Sanofi US. The content contained in this presentation is not eligible for continuing education credit (CME).

View Event →